![Pharmaceutics | Free Full-Text | Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure | HTML Pharmaceutics | Free Full-Text | Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure | HTML](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00047/article_deploy/html/images/pharmaceutics-14-00047-g001.png)
Pharmaceutics | Free Full-Text | Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure | HTML
![Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open](https://bmjopen.bmj.com/content/bmjopen/8/8/e020070/F3.large.jpg)
Development of a population pharmacokinetic model of olanzapine for Chinese health volunteers and patients with schizophrenia | BMJ Open
![Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance - Byon - 2013 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance - Byon - 2013 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/bfa93ba2-7aef-4a83-ac49-d43a9ad90fc6/psp4201326-fig-0002-m.jpg)
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance - Byon - 2013 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![CHARACTERIZATION OF THE TIME-VARYING CLEARANCE OF RITUXIMAB IN NON-HODGKIN'S LYMPHOMA PATIENTS USING A POPULATION PHARMACOKINETIC ANALYSIS METHODS INTRODUCTION. - ppt download CHARACTERIZATION OF THE TIME-VARYING CLEARANCE OF RITUXIMAB IN NON-HODGKIN'S LYMPHOMA PATIENTS USING A POPULATION PHARMACOKINETIC ANALYSIS METHODS INTRODUCTION. - ppt download](https://slideplayer.com/9042066/27/images/slide_1.jpg)
CHARACTERIZATION OF THE TIME-VARYING CLEARANCE OF RITUXIMAB IN NON-HODGKIN'S LYMPHOMA PATIENTS USING A POPULATION PHARMACOKINETIC ANALYSIS METHODS INTRODUCTION. - ppt download
![Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial | Trials | Full Text Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-015-0568-6/MediaObjects/13063_2015_568_Fig2_HTML.gif)
Population pharmacokinetic modeling of the Qishe pill in three major traditional Chinese medicine-defined constitutional types of healthy Chinese subjects: study protocol for a randomized controlled trial | Trials | Full Text
![Session 1: An Introductory Workshop in Population PK/PD Data Analysis with NONMEM® (In Person) - School of Pharmacy and Pharmaceutical Sciences - University at Buffalo Session 1: An Introductory Workshop in Population PK/PD Data Analysis with NONMEM® (In Person) - School of Pharmacy and Pharmaceutical Sciences - University at Buffalo](https://pharmacy.buffalo.edu/content/pharmacy/news-events/events/annual-events/pharmaco-courses/population-pkpd-analysis/_jcr_content/par/image.img.219.auto.jpg/1473256909907.jpg)
Session 1: An Introductory Workshop in Population PK/PD Data Analysis with NONMEM® (In Person) - School of Pharmacy and Pharmaceutical Sciences - University at Buffalo
![Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae | Antimicrobial Agents and Chemotherapy Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01751-19/asset/d5494368-0dcc-4075-acec-829847d3b5d3/assets/graphic/aac.01751-19-f0001.jpeg)
Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae | Antimicrobial Agents and Chemotherapy
![PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram](https://www.researchgate.net/publication/343531547/figure/fig1/AS:930342391250945@1598822319527/PopPK-analysis-prediction-corrected-visual-predictive-check-for-a-acMMAE-and-b.png)
PopPK analysis: prediction-corrected visual predictive check for (a)... | Download Scientific Diagram
![Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression - Clinical Therapeutics Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression - Clinical Therapeutics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/de264430-fbcb-4371-887f-6f65f7f6b7ee/gr1.jpg)
Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression - Clinical Therapeutics
![Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram](https://www.researchgate.net/publication/350105592/figure/fig1/AS:1002218769616898@1615958983061/Overview-of-PopPK-analysis-IIV-inter-individual-variability-PopPK-population.png)
Overview of PopPK analysis. IIV, inter-individual variability; PopPK,... | Download Scientific Diagram
![Frontiers | Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients | Pharmacology Frontiers | Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients | Pharmacology](https://www.frontiersin.org/files/Articles/521331/fphar-11-00340-HTML/image_m/fphar-11-00340-g003.jpg)
Frontiers | Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients | Pharmacology
![Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-020-00859-1/MediaObjects/40262_2020_859_Fig1_HTML.png)
Population Pharmacokinetics of Imipenem in Critically Ill Patients: A Parametric and Nonparametric Model Converge on CKD-EPI Estimated Glomerular Filtration Rate as an Impactful Covariate | SpringerLink
![Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis | PKMS Lab | UBC Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis | PKMS Lab | UBC](https://pkms.ca/publication/fentanyl_jcp/featured.jpg)
Dosing of Continuous Fentanyl Infusions in Obese Children: A Population Pharmacokinetic Analysis | PKMS Lab | UBC
![Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/ad005f80-dc25-46ab-9a47-c326a24d6e98/psp412228-fig-0003-m.jpg)
Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
![Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12959-018-0185-1/MediaObjects/12959_2018_185_Fig4_HTML.png)
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
![Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661818307503-ga1.jpg)